Brevan Howard Capital Management »

Lineage Cell Therapeutics In shares owned by Brevan Howard Capital Management

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Brevan Howard Capital Management from 13F filings

Historical chart of Brevan Howard Capital Management investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Brevan Howard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Brevan Howard Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $295k 187k 1.58
2025-06-30 $281k 309k 0.91

More positions owned by Brevan Howard Capital Management

Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Ishares Tr Iboxx Inv Cp Etf (LQD)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Pdd Holdings Sponsored Ads (PDD)
Ishares Tr China Lg-cap Etf (FXI)
Spdr Gold Tr Gold Shs (GLD)
Select Sector Spdr Tr State Street Fin (XLF)
Agnc Invt Corp Com reit (AGNC)
Ishares Msci Brazil Etf (EWZ)
Meta Platforms Cl A (META)
Palantir Technologies Cl A (PLTR)

View all positions for Brevan Howard Capital Management

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
Vanguard Group
Vanguard Capital Management
Defender Capital
Millennium Management
Raffles Associates
Fifth Third Bancorp
Brian McDonald
BlackRock
Armistice Capital
Geode Capital Management
Renaissance Technologies
Morgan Stanley
UBS Group
Marshall Wace

View all funds holding Lineage Cell Therapeutics In